Embolization of Transarterial Type II Endoleak Using Interlock™ Detachable Coils

BY GUSTAVO S. ODERICH, MD; BERNARDO C. MENDES, MD; AND MARIO D'ORIA, MD 

CASE PRESENTATION

An 85-year-old man presented to outpatient consultation with a persistent type II endoleak 4 years after endovascular aneurysm repair for an infrarenal abdominal aortic aneurysm. Previous medical history included coronary artery disease, pulmonary hypertension, and stage 3 chronic kidney disease. CTA revealed a type II endoleak originating from the inferior mesenteric artery (IMA). There was significant enlargement of the aneurysm sac, which measured up to 6.5 cm in the maximal transverse diameter, compared to 6.2 cm and 5.1 cm 1 and 2 years prior to presentation, respectively. The presence of the type II endoleak was confirmed by contrast-enhanced ultrasound (CEUS), which revealed retrograde filling from the IMA (Figure 1).

Figure 1. Preoperative CTA (A) and CEUS (B) demonstrated the presence of type II endoleak with retrograde flow from a patent IMA (arrows).
Figure 1. Preoperative CTA (A) and CEUS (B) demonstrated the presence of type II endoleak with retrograde flow from a patent IMA (arrows)

PROCEDURE DESCRIPTION

Under general endotracheal anesthesia, the patient was positioned supine, and right percutaneous femoral access was achieved. The superior mesenteric artery (SMA) was selectively catheterized, and contrast injection revealed flow into the IMA via collaterals, confirming the presence of a large type II endoleak originating from the IMA (Figure 2).

Figure 2. Intraoperative angiography showed placement of a coaxial system within the SMA (A) and identified the large SMA-IMA collateral (B). Successful retrograde navigation through the middle colic artery down to the IMA (C) with confirmation of retrograde flow within the aneurysm sac (arrow).
Figure 2. Intraoperative angiography showed placement of a coaxial system within the SMA (A) and identified the large SMA-IMA collateral (B). Successful retrograde navigation through the middle colic artery down to the IMA (C) with confirmation of retrograde flow within the aneurysm sac (arrow).
Using a Renegade® STC Microcatheter (Boston Scientific Corporation) and a Glidewire® Gold hydrophilic guidewire (Terumo Interventional Systems), the middle colic artery and IMA were selectively catheterized. The microcatheter was then advanced into the aneurysm sac, which was excluded using numerous Interlock™-18 Detachable Coils (Boston Scientific Corporation). The proximal IMA was also embolized using Interlock™-18 Detachable Coils. Completion angiography revealed successful exclusion of the IMA with no evidence of residual endoleak (Figure 3). The postoperative course was uneventful, and the patient was discharged home on postoperative day 1.
Figure 3. Completion angiography showed a widely patent SMA (A) and IMA distally to the placed coils with absence of residual sac filling (B).
Figure 3. Completion angiography showed a widely patent SMA (A) and IMA distally to the placed coils with absence of residual sac filling (B).

DISCUSSION

Endoleaks are the most common event after endovascular aneurysm repair; lifelong surveillance is recommended because their persistence may lead to aneurysm sac expansion and aortic rupture.1 Treatment of type II endoleak has been a topic of significant controversy. Support for conservative management derives from the estimated low risk of late rupture secondary to isolated type II endoleak.2 However, although some authors have argued that prophylactic embolization in selected patients can decrease the risk of persistent type II endoleak and aneurysm sac growth,3 most would use a strategy of selective secondary intervention in the presence of significant aneurysm sac expansion, which is supported by current guidelines.4

Access to the aneurysm sac can be achieved via multiple approaches depending on type II endoleak location and delineation based on preoperative imaging. The transarterial approach usually represents the first-line option.5 When the IMA is involved, an SMA-to-IMA access (via the arc of Riolan or marginal artery of Drummond) may be chosen. Once stable access is achieved and an introducer sheath can be advanced in the proximal SMA, a floppy system composed of a microcatheter and microwire (similar to the combination utilized in the presented case) is preferred to navigate through the collateral into the IMA and the aortic aneurysm sac. Alternatively, the authors have found the 0.014-inch Fathom™ Steerable Guidewire (Boston Scientific Corporation) to have excellent steerability.

Complete obliteration of the endoleak nidus with elimination of all inflow and outflow vessels is required to prevent recurrence and can be achieved with different materials, typically a combination of plugs, coils, and/or Onyx™ liquid embolic (Medtronic). One benefit of Onyx™ is its ability to advance beyond the site of delivery and disperse through the endoleak nidus to fill the ingress and egress vessels. Being radiopaque, it can be closely followed under fluoroscopic guidance, and injection may be stopped if there is inadvertent nontarget delivery. Coils represent a feasible alternative, allowing for easy trackability during the procedure and quick placement within small vessels. In the case described in this article, the choice of coils was based on their accurate deployment and control because of the detachable mechanism and polyethylene terephthalate fibered structure, which is highly thrombogenic and provides a uniquely stable, permanent platform for blood stasis, thrombus organization, and neointima formation. To avoid persistent flow through the coils, care must be taken to ensure they are properly packaged within the endoleak nidus. Finally, plugs can safely and effectively occlude the target vessel right at the ostium, preserving any anastomosis that remains patent.

Although generally safe, secondary interventions for type II endoleak are often unsatisfactory because persistence/recurrence are commonly encountered.6 Therefore, follow-up imaging is key to evaluate technical and clinical success. Type II endoleak persistence/recurrence may be difficult to identify in the presence of Onyx™ or coils, because both cause significant scatter artifact on CTA. However, sac diameter measurements are usually not inhibited by the artifact and, when combined with duplex ultrasound and/or CEUS, recurrent flow within the sac can still be estimated with reasonable certainty.

CONCLUSION

Treatment of type II endoleak can be performed safely and effectively utilizing several approaches. When a transarterial route is performed, appropriate utilization of a support system into the SMA or internal iliac artery is recommended, followed by use of a microcatheter and a steerable microwire. Treatment is usually accomplished with a combination of plugs, coils, and/or Onyx™. Continued imaging follow-up after type II endoleak treatment is required to identify persistence/recurrence as well as stabilization or regression of the aneurysm sac.

Gustavo S. Oderich, MD
Professor of Surgery
Division of Vascular and Endovascular Surgery
Mayo Clinic
Rochester, Minnesota
oderich.gustavo@mayo.edu
Disclosures: None.

Bernardo C. Mendes, MD
Assistant Professor of Surgery
Division of Vascular and Endovascular Surgery
Mayo Clinic
Rochester, Minnesota
mendes.bernardo@mayo.edu
Disclosures: None.

Mario D’Oria, MD
Ted Rogers Research Fellow
Division of Vascular and Endovascular Surgery
Mayo Clinic
Rochester, Minnesota
Disclosures: None.

Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

View Full Supplement

 

 

Renegade STC 18 Microcatheter

CAUTION: Federal law (USA) restricts this device to sale by or on the order of a physician. Rx only. Prior to use, please see the complete “Directions for Use” for more information on Indications, Contraindications, Warnings, Precautions, Adverse Events, and Operator’s Instructions.

INTENDED USE/INDICATIONS FOR USE The Renegade STC 18 Microcatheter is intended for peripheral vascular use. The microcatheter can be coaxially tracked over a steerable guidewire in order to access distal, tortuous vasculature. Once the subselective region has been accessed, the microcatheter can be used for the controlled and selective infusion of diagnostic, embolic, or therapeutic materials into vessels. Diagnostic, embolic, therapeutic agents to be used in accordance with specifications outlined by the manufacturer.

CONTRAINDICATIONS None Known.

WARNING The Renegade STC 18 Microcatheter is not intended for use in the coronary vasculature or the neurovasculature.

PRECAUTIONS •This device should be used only by physicians thoroughly trained in percutaneous, intravascular techniques and procedures. •Never advance or withdraw an intravascular device against resistance until the cause of the resistance is determined by fluoroscopy. Movement of the microcatheter or guidewire against resistance may result in separation of the microcatheter or guidewire tip, damage to the microcatheter or guidewire tip, or vessel perforation. •Because the microcatheter may be advanced into narrow subselective vasculature, repeatedly assure that the microcatheter has not been advanced so far as to interfere with its removal.

ADVERSE EVENTS The Adverse Events include, but are not limited to: •Vessel trauma •Embolism •Hemorrhage/Hematoma •Vasospasm •Infection •Air embolism •Allergic reaction

90960758 Rev/Ver. AB

Interlock Fibered IDC Occlusion System

CAUTION: Federal law (USA) restricts this device to sale by or on the order of a physician. Rx only. Prior to use, please see the complete “Directions for Use” for more information on Indications, Contraindications, Warnings, Precautions, Adverse Events, and Operator’s Instructions.

INTENDED USE/INDICATIONS FOR USE The Interlock Fibered IDC Occlusion System is a modified interlocking detachable coil indicated to obstruct or reduce rate of blood flow in the peripheral vasculature. This device is not intended for neurovascular use.

CONTRAINDICATIONS None known.

GENERAL PRECAUTIONS Do not advance the Interlock Fibered IDC Occlusion System if it becomes lodged within the microcatheter. Determine the cause of the resistance and replace the microcatheter and coil if necessary.

ADVERSE EVENTS The complications that may result from a peripheral embolization procedure include, but are not limited to: •Complications related to catheterization (e.g., hematoma at the site of entry, vessel injury, etc.) •Death •Emboli •Foreign body reactions necessitating medical intervention •Hemorrhage •Infection necessitating medical intervention •Ischemia •Pain •Recanalization •Temporary neurological deficit •Tissue necrosis •Undesirable clot formation of the vasculature •Vasospasm

90960711 Rev/Ver. AB

 

 

Customer Support

Customer Support

If you need any additional information or have questions, feel free to reach out to our support team.

Button
Request a Rep

Request a Rep

To learn more about our products and services, enter your info and a sales representative will contact you.

Button
Sign up for the PI POV newsletter

Join Our Community

Sign up to receive our newsletter.

Button
Top